[Pathophysiological significance of endothelin in pulmonary hypertension].
Yoshibayashi
Muneo
M
Department of Pediatrics, Nara Hospital, Kinki University School of Medicine.
D015415:Biomarkers / Q000097:blood; D000077300:Bosentan; D002455:Cell Division; D015195:Drug Design; D065128:Endothelin Receptor Antagonists; D016232:Endothelins / Q000097:blood / Q000502:physiology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D009119:Muscle Contraction; D009131:Muscle, Smooth, Vascular / Q000166:cytology; D012720:Severity of Illness Index; D013449:Sulfonamides / Q000627:therapeutic use
D015415:Biomarkers; D065128:Endothelin Receptor Antagonists; D016232:Endothelins; D013449:Sulfonamides; D000077300:Bosentan